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Are 25(OH) D concentrations associated with asthma 
control and pulmonary function test? 
 
Abstract 
Background: The relationship between vitamin D and asthma is still under investigation. 
We aimed to evaluate the association between serum vitamin D levels and clinical 
characteristics of asthma, and the impact of vitamin D deficiency on the clinical 
manifestations, as them being the issues of debate. 
Methods: Patients who were admitted to the outpatient clinics of Chest Diseases 
Department of Akdeniz University Hospital between January 2014 and December 2014, 
have been diagnosed as asthma according to the GINA 2014 guidelines were included in 
this study. Subjects with COPD, bronchiectasis, pneumonia or tuberculosis were excluded. 
Asthma exacerbation was defined, according to the GINA guidelines, as episodes of 
progressive shortness of breath, cough, wheezing or chest tightness accompanied by PFT 
abnormalities such as decreased PEF or FEV1. 
Results: A total of 158 patients with mean age of 48.8 years were included in the study. 
Twenty-seven (17.08%) of the patients demonstrated sufficient vitamin D serum levels 
(i.e. ≥30 ng/mL), while the remaining 131 (82.92%) patients had vitamin D insufficiency 
(i.e. <30 ng/mL). When these two patient groups (vitamin D sufficient vs. insufficient) 
were compared with each other, the patients showing sufficient levels of vitamin D were 
found to reveal significantly higher FEV1 (L) and FVC (L) values. When the patients were 
grouped into 4 categories with regard to their serum vitamin D measurements, hospitalization 
numbers were found to significantly increase with decreasing vitamin D levels. 
Conclusion: Vitamin D deficiency was significantly associated with poorer pulmonary 
functions and higher hospitalization numbers. 
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Asthma is a chronic and inflammatory airway disease which is under the influence 
of both genetic and environmental factors. Genetic predisposition is among the most 
important risk factors for the development of the disease. On the other hand, they are 
mostly the environmental factors that trigger the exacerbations (1). It is thought that both 
gene-gene and gene-environment interactions may increase the individuals’ predisposition 
to asthma. A strong correlation between genetic background and susceptibility to allergic 
diseases is well established; nonetheless, changes in the global environmental conditions 
also are accepted to be an important factor which is responsible for the increasing 
prevalence rates (1, 2). Several theories have been suggested to explain this increasing 
prevalence of allergy, namely the hygiene and diet hypotheses. The components that the 
diet hypothesis focuses on can be listed as antioxidants, lipids and other nutrients, food 
types and dietary patterns, breast milk, probiotics and intestinal microbiota, vitamin D, and 
maternal diet (3). The relationship between vitamin D and asthma is still under 
investigation.
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Some authors have reported that supplementation with 
vitamin D might result in asthma; whereas there are others 
suggesting a negative correlation between asthma and 
vitamin D (4-6). It has been emphasized in epidemiological 
studies that vitamin D deficiency is associated with increased 
asthma symptoms (4). Evidence supporting the significance 
of vitamin D in immune regulation has been growing. 
Besides its calcemic effects, the association of vitamin D 
with several disease conditions has recently been being 
investigated, and it has been suggested not only to have 
important roles in the pathogenesis of, but also to be a 
beneficial treatment option for many. In the NHANES III 
study, upper respiratory tract infections were found to be 
more common in patients with low vitamin D levels (7). 
There are studies reporting that steroid use in severe asthma 
is associated with vitamin D levels (8).  Here in this study, 
we aimed to evaluate the association between serum vitamin 
D levels and clinical characteristics of asthma, and the 
impact of vitamin D deficiency on the clinical 
manifestations, as them being issues of debate.                                     
 
 
Methods 
Patients who were admitted to the outpatient clinics of 
Chest Disease Department of Akdeniz University Hospital 
between January 2014 and December 2014, older than 18 
years were included this study. All records were 
retrospectively screened.  The diagnosis of asthma was made 
according to the Global Initiative for Asthma (GINA) 2014 
guideline included in this study (2).  Patients with vitamin D 
levels measured for any reason were included in the study; 
while those with asthma who were not evaluated for vitamin 
D levels and those with COPD, bronchiectasis, pneumonia or 
tuberculosis were excluded. The sample group consisted of 
patients with asthma and measured vitamin D levels. Age 
and gender data, pulmonary function tests (PFT), smoking 
history, bronchodilator drugs, comorbid diseases 
(cardiovascular diseases, neurological diseases, 
endocrinological diseases, malignancies etc), number of 
attacks in 1 year, and hospitalization were recorded. Asthma 
was diagnosed when patients had symptoms such as episodic 
breathlessness, wheezing, cough, and chest tightness, and 
whose spirometry showed bronchial reversibility as 12% and 
200 mL from the prebronchodilator value or airway hyperre-
sponsiveness as provocative concentration of a methacholine 
causing a 20% fall in forced expiratory volume in 1 second 
(FEV1) was below 25 mg/mL. Asthma exacerbation was 
defined, again according to the GINA guidelines, as episodes 
of progressive shortness of breath, cough, wheezing or chest 
tightness accompanied by PFT abnormalities such as 
decreased PEF or FEV1.  They were treated with steroids 
and rapid-acting inhaled β-agonists. Pulmonary functions 
was tested with a spirometer (CareFusion Germany 234 
GmbH Yorba Linda, CA 92887). The spirometer was 
calibrated once daily with a 3-L syringe, according to the 
operator’s manual. Each patient was tested at least 3 times. 
The best value was expressed as a percentage of the 
predicted value and as an absolute value. To assess the 
vitamin D status of the subjects, serum 25-(OH)-vitamin D 
measurements were performed using high-performance 
liquid chromatography. Serum 25-(OH)-vitamin D levels of 
≤20 ng/mL were interpreted as vitamin D deficiency, levels 
of between 21-29 ng/mL as vitamin D insufficiency and 
levels of ≥30 ng/mL as sufficient. Each patient has 
performed an asthma control test, as suggested by the GINA 
2014 guidelines (2). Statistical analysis was performed with 
PASW 20 (SPSS / IBM, Chicago, IL, USA). To define 
sample frequency distribution, mean, standard deviation as 
descriptive statistics was used. Continuous variables were 
compared with student’s t test. The chi-square or Fisher 
exact test was used to compare categorical variables. All p-
values are from 2-tailed tests and p-values less than 0.05 
were considered statistically significant. 
 
 
Results 
A total of 158 patients with mean age of 48.8 years were 
included in the study. Table 1 summarizes the fundamental 
characteristics of the subjects. The most commonly 
prescribed treatment regimen was the combination of inhaled 
corticosteroids + long-acting beta-2 agonists + montelukast. 
Distribution of the patients according to their serum vitamin 
D levels is shown in figure 1. Twenty-seven (17.08%) of the 
patients demonstrated sufficient vitamin D serum levels (i.e. 
≥30 ng/mL), while the remaining 131 (82.92%) patients had 
vitamin D insufficiency (i.e. <30 ng/mL). When these two 
patient groups (vitamin D sufficient vs. insufficient) were 
compared with each other, the patients showing sufficient 
levels of vitamin D were found to reveal significantly higher 
FEV1 (L) and FVC (L) values. All other parameters 
investigated were comparable between these two groups 
(Table 2).  
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Table 1. Basic characteristics of patients 
 
Characteristics Features Data 
Age (mean±SD) (years) 48.8±14.5 
Sex (%, n) Male 27.2 (43) 
 Female 72.7(115) 
Smoking history (%, n) + 
- 
20.8 (33) 
79.1(125) 
25 OH Vitamin (mean±SD)  21.3±14.1 
Pulmonary function tests 
(mean±SD) 
FEV1(%) 
FEV1 (L) 
FVC (%) 
FVC (L) 
80.3±22.1 
2.4±3.3 
82.1±21.7 
2.9±3.2 
History of exacerbation (previous 
year) (%, n) 
+ 
- 
29.7 (47) 
70.2(111) 
History of hospitalization (previous 
year) (%, n) 
+ 
- 
7.5 (12) 
92.4 146) 
Steroid requirement (%, n) + 
- 
18.9 (30) 
81.0(127) 
Asthma control test (mean±SD)  17.7±4.7 
Comorbidities  (%, n) + 
- 
59.4 (94) 
40.5 (64) 
FEV1: forced expiratory volume in 1 second, FVC:forced vital capacity, SD: 
standard deviation 
 
 
Table 2. Clinical characteristics and pulmonary function 
tests of patients according to the level of vitamin D 
 
 Vitamin D   
 (<30 
ng/mL) 
(n:131) 
(≥30 
ng/mL) 
(n:27) 
p 
FEV1 (%) (mean±SD) 79.5±22.5 83.7±19.6 0.578 
FEV1 (L) (mean±SD) 2.2±0.8 3.7±7.8 0.001 
FVC % (mean±SD) 82.3±20.5 81.2±27.3 0.133 
FVC (L) (mean±SD) 2.6±1.0 4.1±7.6 0.001 
Exacerbation (%,n) 31.3 (41) 22.2 (6) 0.348 
Steroid requirement (%,n) 20.8 (27) 11.1 (3) 0.245 
Hospitalization (%,n) 7.6 (10) 7.4 (2) 0.968 
Smoking history (+) (%,n) 19.1 (25) 29.6 (8) 0.220 
Comorbidities (+) (%,n) 58.8 (77) 63.0 (17) 0.687 
Asthma Control Test 
(mean±SD) 
17.1±4.7 20.3±3.7 0.001 
FEV1: forced expiratory volume in 1 second, FVC: forced vital capacity, 
SD: standard deviation 
Table 3. The impact of vitamin D levels on asthma 
severity and pulmonary function tests 
FEV1: forced expiratory volume in 1 second, FVC:forced vital capacity, 
SD: standard deviation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Vitamin D status in the studied patients with 
asthma 
 
 
Discussion 
The relationship between vitamin D and asthma is still a 
subject of investigation. Some previous studies have 
identified vitamin D as a causative factor for asthma, and 
some others as a protective agent from the disease. Yet other 
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reports have claimed that vitamin-D deficiency deteriorates 
asthma control (4, 6, 9). In this work, approximately 70% of 
our patients showed insufficient vitamin D levels. We have 
found that vitamin D deficiency results in increased numbers 
of hospitalization in patients with asthma and that vitamin D 
insufficiency is associated with poorer pulmonary function 
test results.  
It is estimated that nearly 1 billion people throughout the 
world have abnormal vitamin D levels. Presence of vitamin 
D deficiency has previously been reported in healthy 
children, young adults, middle-aged individuals and geriatric 
population (10, 11). A previous study by Freishtat et al. (12) 
focusing on vitamin D deficiency in asthma, which was 
performed on young Afro-Americans living in the urban area 
detected higher prevalence rates of vitamin D deficiency 
than the control group. Our results revealed a similar vitamin 
D insufficiency rate of 88.92% among the subjects with 
asthma.  
Sutherland et al. (13) reported the mean serum vitamin D 
levels of the adults with asthma as 28.1 ng/mL and found 
that serum vitamin D level is associated with a better 
pulmonary function. Our study revealed a mean serum 
vitamin D level of 21.3 ng/mL in the asthma group. Black et 
al. (14) reviewed the data from the NHANES III study which 
had been held in the USA on 14,091 subjects and they found 
that women had significantly lower mean vitamin D levels 
than men (28.72 ng/mL vs. 31, 37 ng/mL). The authors 
suggested that these results might be due to the women’s 
preference for closed clothing for religious reasons, or their 
using of sun creams for cosmetic reasons or for protection 
against skin cancer. There were more females than males 
included in our study, which may be one reason for our 
higher vitamin D insufficiency rates when compared with the 
previous literature.  
Respiratory infections, one condition that is responsible 
for the flare-ups in asthma patients, are known to be 
associated with lower vitamin D levels (9). Viruses are the 
most commonly blamed agents for these exacerbations (15-
17). In some studies, patients with high vitamin D levels 
were found to show reduced needs for hospitalization over 
the past one year. The same studies also documented that 
higher levels of vitamin D are associated with a lower 
requirement for anti-inflammatory drugs (9, 18). In our 
study, vitamin D deficient patients showed higher 
hospitalization rates; however, the groups were statistically 
comparable with regard to need for steroid medication.  
Zosky et al. (19) conducted an animal experiment to 
reveal whether vitamin D deficiency affects the structure and 
function of the lungs. In that study, the authors showed that 
although vitamin D does not alter the somatic growth of the 
lungs and that the histological structure is almost completely 
conserved, it leads to decreased lung volumes. The authors 
concluded that vitamin D deficiency caused deficits in the 
lung function which was mainly due to alterations in the lung 
volume, and suggested that that finding might be an 
explanation of the association between obstructive 
pulmonary diseases and vitamin D. In recent studies, vitamin 
D has been thought to have a positive effect on pulmonary 
functions. In the study by Black et al. (14), serum vitamin D 
levels were established to be strongly associated with FEV1 
and FVC, after standardization of the data for age, gender, 
ethnicity, body mass index (BMI) and smoking history. 
Similarly, the results of a Chinese study on 435 asthma 
patients demonstrated that vitamin D levels were positively 
correlated with FEV1 (expected %) and FEV1/FVC 
(expected %) values (20). In our study, there was a positive 
correlation between vitamin D levels and pulmonary 
function tests.  
The relationship between vitamin D and asthma severity 
indicators, such as asthma control, exacerbations, total IgE 
levels, eosinophil counts and number of hospitalizations for 
the past 1 year has been investigated. In the study by Ginde 
et al. (7) on the NHANES III data, which included a total of 
18, 883 patients, an association between lower levels of 
vitamin D and higher rates of upper respiratory tract 
infections was demonstrated. In that study, it was shown that 
the association between the increased respiratory tract 
infection rates and vitamin D levels was more pronounced in 
the asthma group. It was also demonstrated that asthma 
attacks were more severe with lower vitamin D levels. The 
patients with and without sufficient serum vitamin D levels 
were statistically comparable in terms of asthma 
exacerbation and hospitalization numbers. However, as 
vitamin D deficiency deepened, hospitalization rates 
increased significantly.   
There are number of studies showing that vitamin D 
deficiency is associated with suboptimal asthma control (21, 
22). In our study, vitamin D deficiency did not lead to a 
significant change in the severity classification of asthma. It 
was also detected that, in the asthmatic patient group, 
vitamin D deficiency did not significantly affect asthma 
control. The mean asthma control test score of the stable 
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asthma patients with vitamin D deficiency did not differ 
significantly from that of the patients with normal vitamin D 
levels. According to these findings, it may be concluded that 
no significant association is present between vitamin D 
levels and clinical manifestations of asthma.  
Our study had a number of limitations, which should be 
considered when interpreting the results. These limitations 
can be summarized as follows: relatively small number of 
the patients that were included; not completely taking the 
factors that might affect the vitamin D levels of the 
individuals into account, such as diet, sun exposure and 
clothing style; not performing food frequency questionnaire; 
not analyzing for genetic determinants of vitamin D 
resistance in the blood samples; not taking seasonality into 
account; not re-evaluating the subjects with vitamin D 
deficiency upon completing their replacement therapy. 
According to the results of this present study, it was 
found that serum vitamin D levels and deficiency rates were 
similar between the asthmatic patients and the control group, 
but vitamin D deficiency was significantly associated with 
poorer pulmonary functions and higher hospitalization 
numbers. Further better planned studies are needed to 
determine the effect of vitamin D on asthma control. 
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